Evidence map›Paper›PMID 40236977›Full record

ArticleARYA atherosclerosis2022

Rationale, Design, and Initial Findings of Community Trial on Improving the Iranian's Knowledge and Practice of Dyslipidemia Management, Prevention, and Control.

Noushin Mohammadifard, Maryam Maghroun, Marzieh Taheri, Marjan Mansourian, Farid Najai, Hossein Farshidi, Tooba Kazemi, Masoud Lot Izadeh, Kamal Solati, Ali Pourmoghaddas and 7 more

Abstract read
In one paragraph

Article in ARYA atherosclerosis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Noushin MohammadifardIsfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Maryam MaghrounInterventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Marzieh TaheriHeart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Marjan MansourianDepartment of Epidemiology and Biostatistics, Health School, Isfahan University of Medical Sciences, Iran.
Farid NajaiResearch Center for Environmental Determinants of Health, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Hossein FarshidiHormozgan Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandarabbas, Iran.
Tooba KazemiCardiovascular Disease Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Masoud Lot IzadehSocial Determinants of Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Kamal SolatiDepartment of Psychiatry, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Ali PourmoghaddasInterventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Hassan AlikhasiHypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Jamshid Naja IanHypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Masoumeh SadeghiCardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Katayoun RabieiPediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Hamidreza RoohafzaCardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Mahammadreza SabriPediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Nizal SarrafzadeganIsfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To investigate the effects of comprehensive, i ntegrated i nterventions on dyslipidemia Knowledge and Practices (LIPOKAP) using population and high-risk approaches. Method: The baseline of this national, multicentric community trial was conducted on three groups: the general population (adults over the age of 18 and their children aged 6-18), patients with dyslipidemia and their caregivers, and health professionals (physicians, nurses, health providers, and health workers). The general population was selected using multi-stage random sampling, while patients and health professionals were recruited using the consecutive sampling method. The research was carried out in urban and rural areas of five Iranian counties. The sampling method and sample size were similar in baseline and post-intervention surveys. Approximately 8-month intervention programs were carried out on the target groups, which generally included educational strategies. The intervention activities addressed the management, prevention, and control and were tailored to each target group, focusing on lifestyle and self-care. Results: All questionnaires' content validity ratio, content validity index, and Cronbach's alpha were over 0.68, 0.83, and 0.73, respectively. We enrolled 2456 adults and 850 of their children, 3331 dyslipidemia patients, 1699 caregivers, and 1800 health professionals. Conclusions: The validity and reliability of all developed questionnaires that can examine knowledge and practice changes as a result of intervention activities were acceptable.

Indexed as

And QuestionnairesDyslipidemiasGeneral PracticeHyperlipidemiasKnowledgeProfessional PracticeResearch DesignSurveys

Identifiers

PMID40236977
PMCPMC11994867

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.